Physician profile
Marla Guzman
NPI 1285052662
$1,010.88
in general payments reported to CMS, 2019-2025
17 companies · $583 in 2025
The $583 reported for 2025 was more than what 76% of Pediatric Rheumatology providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.42 · 2020: $21.95 · 2024: $343 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $925.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $171.36 | 2019-2025 | Benlysta |
| Sobi, INC | $160.36 | 2025 | |
| Novartis Pharmaceuticals Corporation | $138.72 | 2024-2025 | |
| Pfizer INC. | $126.86 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $94.37 | 2024-2025 | Orencia |
| Amphastar Pharmaceuticals, INC. | $51.04 | 2024-2025 | |
| Abbvie INC. | $48.07 | 2025 | |
| Boston Scientific Corporation | $46.75 | 2019 | |
| Azurity Pharmaceuticals, INC. | $35.35 | 2025 | Triptodur |
| Alexion Pharmaceuticals, INC. | $21.95 | 2020 | |
| Baxter Healthcare | $21.11 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Harmony Biosciences LLC | $18.27 | 2025 | |
| Tolmar, INC. | $17.96 | 2025 | Fensolvi |
| Genentech USA, INC. | $16.58 | 2025 | Actemra |
| Aimmune Therapeutics, INC. | $14.68 | 2025 | Zenpep |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rhythm Pharmaceuticals, INC. | $14.04 | 2025 | Imcivree |
| Novo Nordisk INC | $13.41 | 2024 | Sogroya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marla Guzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.